上海华源安徽锦辉制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
156
NMPA:156
Drug Approvals
Low Calcium Peritoneal Dialysis Solution (Lactate-G1.5%)
- Product Name
- 低钙腹膜透析液(乳酸盐-G1.5%)
- Approval Number
- 国药准字H20243179
- Approval Date
- Feb 6, 2024
NMPA
Low Calcium Peritoneal Dialysis Solution (Lactate-G2.5%)
- Product Name
- 低钙腹膜透析液(乳酸盐-G2.5%)
- Approval Number
- 国药准字H20243178
- Approval Date
- Feb 6, 2024
NMPA
Dextran 40 Glucose Injection
- Product Name
- 右旋糖酐40葡萄糖注射液
- Approval Number
- 国药准字H34021616
- Approval Date
- Nov 2, 2021
NMPA
Compound Amino Acid Injection(18AA)
- Product Name
- 复方氨基酸注射液(18AA)
- Approval Number
- 国药准字H19993772
- Approval Date
- Nov 2, 2021
NMPA
Azithromycin and Glucose Injection
- Product Name
- 弗奇
- Approval Number
- 国药准字H20040534
- Approval Date
- Nov 2, 2021
NMPA
Compound Amino Acid Injection(17AA)
- Product Name
- 复方氨基酸注射液(17AA)
- Approval Number
- 国药准字H19993755
- Approval Date
- Nov 2, 2021
NMPA
Dextran 40 Glucose Injection
- Product Name
- 右旋糖酐40葡萄糖注射液
- Approval Number
- 国药准字H34021615
- Approval Date
- Nov 2, 2021
NMPA
Azithromycin and Glucose Injection
- Product Name
- 弗奇
- Approval Number
- 国药准字H20060429
- Approval Date
- Nov 2, 2021
NMPA
Sodium Bicarbonate Injection
- Product Name
- 碳酸氢钠注射液
- Approval Number
- 国药准字H34021512
- Approval Date
- Aug 11, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found